Environmental factors potentially associated with mumps transmission in Yeshivas during a mumps outbreak among highly vaccinated students Brooklyn, New York, 2009-2010

Human Vaccines and Immunotherapeutics

Volumn 9, Issue 1, 2013, Pages 189-194

  Fiebelkorn, Amy Parker ^a   Rosen, Jennifer B ^b   Brown, Cedric ^a   Zimmerman, Christopher M ^b   Renshowitz, Hyman ^b   D'Andrea, Christopher ^b   Gallagher, Kathleen M ^c   Harpaz, Rafael ^a   Zucker, Jane R ^a,b  

^a NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^b NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Environmental risk factors; High MMR vaccine coverage; Mumps; Mumps outbreak; Mumps transmission

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ADOLESCENT; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ASSOCIATION; ENVIRONMENTAL FACTOR; EPIDEMIC; HUMAN; HUMAN RELATION; INFECTION RATE; LEARNING ENVIRONMENT; MAJOR CLINICAL STUDY; MALE; MUMPS; POPULATION DENSITY; SCHOOL; SCHOOL CHILD; SELF REPORT; TREND STUDY; UNITED STATES; VACCINATION; VIRUS TRANSMISSION;

ENVIRONMENTAL RISK FACTORS; HIGH MMR VACCINE COVERAGE; MUMPS; MUMPS OUTBREAK; MUMPS TRANSMISSION;

ADOLESCENT; DISEASE OUTBREAKS; HUMANS; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; NEW YORK; RISK FACTORS; STUDENTS; TREATMENT FAILURE;

EID: 84874743325     PISSN: 21645515     EISSN: 2164554X     Source Type: Journal    
DOI: 10.4161/hv.22415     Document Type: Article

References (23)

1. Plotkin SA, Rubin SA. Mumps vaccine. In: Plotkin SA, Orenstein WA, Offit P, eds. Vaccines 5th ed: Elsevier Inc., 2008:435-65.
2. Barskey AE, Glasser JW, LeBaron CW. Mumps resurgences in the United States: A historical perspective on unexpected elements. Vaccine 2009; 27:6186-95; PMID:19815120; http://dx.doi.org/10.1016/j.vaccine.2009.06.109.
3. Meyer MB. An epidemiologic study of mumps; its spread in schools and families. Am J Hyg 1962; 75:259-81; PMID:14473149.
4. Brooks H. Epidemic parotitis as a military disease. Med Clin North Am 1918; 2:492-505.
5. Centers for Disease Control and Prevention. Mumps Vaccine. MMWR 1977; 26:393-4.
6. Centers for Disease Control. Measles prevention. MMWR 1989; 38(Suppl 9):1-18; PMID:2513473.
7. Watson JC, Hadler SC, Dykewicz CA, Reef S, Phillips L; Centers for Disease Control and Prevention. Measles, mumps, and rubella-vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1998; 47(RR-8):1-57; PMID:9639369.
8. Dayan GH, Quinlisk MP, Parker AA, Barskey AE, Harris ML, Schwartz JM, et al. Recent resurgence of mumps in the United States. N Engl J Med 2008; 358:1580-9; PMID:18403766; http://dx.doi.org/10.1056/NEJMoa0706589.
9. Barskey AE, Schulte C, Rosen JB, Handschur EF, Rausch-Phung E, Doll MK, et al. Mumps Outbreak in Orthodox Jewish Communities in the United States, 2009-10. N Engl J Med, In press.
10. Centers for Disease Control and Prevention. Healthcare Worker Exclusion. Mumps Prevention and Control in Healthcare Settings. 2012; Available from: http://www.cdc.gov/mumps/prev-control-settings/hcw-exclusion. html.
11. Parker Fiebelkorn A, Barskey AE, Hickman C, Bellini W. Mumps. In: Centers for Disease Control and Prevention, ed. Manual for the Surveillance of Vaccine-Preventable Diseases 2012; Available from: http://www.cdc.gov/vaccines/ pubs/surv-manual/chpt09-mumps. html.
12. U.S. Department of Education. National Center for Education Statistics. Private School Universe Survey (PSS). Average length of school year and average length of school day for private schools, by selected characteristics: United States, 2005-06. Washington, DC U.S. Department of Education, 2006.
13. U.S. Department of Education. National Center for Education Statistics. Average class size for school teachers in elementary schools, secondary schools, and schools with combined grades, by classroom type, school type, and selected school characteristics: 2007-08. 2007-08.
14. Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: are two doses enough? Epidemiol Infect 2012; 140:439-46; PMID:21554780; http://dx.doi.org/10.1017/ S095026881100063X.
15. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 2010; 15:15; PMID:20460086.
16. Roberts C, Porter-Jones G, Crocker J, Hart J. Mumps outbreak on the island of Anglesey, North Wales, December 2008-January 2009. Euro Surveill 2009; 14; PMID:19215718.
17. Bangor-Jones RD, Dowse GK, Giele CM, van Buynder PG, Hodge MM, Whitty MM. A prolonged mumps outbreak among highly vaccinated Aboriginal people in the Kimberley region of Western Australia. Med J Aust 2009; 191:398-401; PMID:19807634.
18. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13:12-7; PMID:17370510.
19. Deeks SL, Lim GH, Simpson MA, Gagné L, Gubbay J, Kristjanson E, et al. An assessment of mumps vaccine effectiveness by dose during an outbreak in Canada. CMAJ 2011; 183:1014-20; PMID:21576295; http://dx.doi.org/10.1503/cmaj. 101371.
20. Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, LeBaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students-Iowa, 2006. Vaccine 2008; 26:3601-7; PMID:18539365; http://dx.doi.org/10.1016/j.vaccine.2008.04.075.
21. Cheek JE, Baron R, Atlas H, Wilson DL, Crider RD Jr. Mumps outbreak in a highly vaccinated school population. Evidence for large-scale vaccination failure. Arch Pediatr Adolesc Med 1995; 149:774-8; PMID:7795768; http://dx.doi.org/10.1001/archpedi. 1995.02170200064010.
22. Escombe AR, Oeser CC, Gilman RH, Navincopa M, Ticona E, Pan W, et al. Natural ventilation for the prevention of airborne contagion. PLoS Med 2007; 4:e68; PMID:17326709; http://dx.doi.org/10.1371/journal. pmed.0040068.
23. Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, et al. Seroepidemiology of mumps in Europe (1996-2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect 2012:1-16; PMID:22687578; http://dx.doi.org/10.1017/S0950268812001136.